Prospects for Treatment of Latent HIV

被引:77
作者
Barton, K. M. [1 ]
Burch, B. D. [2 ]
Soriano-Sarabia, N. [2 ]
Margolis, D. M. [1 ,2 ,3 ]
机构
[1] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Dept Med, Chapel Hill, NC USA
[3] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA
关键词
T-CELLS; DEACETYLASE INHIBITORS; GENE-EXPRESSION; PD-1; BLOCKADE; IN-VIVO; ACTIVATION; RESISTANCE; INFECTION; DISEASE; CXCR4;
D O I
10.1038/clpt.2012.202
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Recent advances in antiretroviral therapy (ART) have drastically improved the quality of life for people with HIV infection. However, owing to the persistence of latent HIV in the presence of therapy, patients must remain on therapy indefinitely. Currently, the solution to the HIV pandemic rests on the prevention of new infections and many decades of ART for the steadily expanding number of people infected worldwide. ART is costly, requires ongoing medical care, and can have side effects, thereby preventing its universal availability. Therefore, to escape the ironic burdens of therapy, efforts have begun to develop treatments for latent HIV infection. Current approaches propose either complete eradication of infection or induction of a state of stringent control over viral replication without ART. This review will discuss these strategies in detail and their potential for clinical development.
引用
收藏
页码:46 / 56
页数:11
相关论文
共 75 条
[61]   HIV-1 proviral DNA excision using an evolved recombinase [J].
Sarkar, Indrani ;
Hauber, Ilona ;
Hauber, Joachim ;
Buchholz, Frank .
SCIENCE, 2007, 316 (5833) :1912-1915
[62]   BIOLOGICAL PHENOTYPE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CLONES AT DIFFERENT STAGES OF INFECTION - PROGRESSION OF DISEASE IS ASSOCIATED WITH A SHIFT FROM MONOCYTOTROPIC TO T-CELL-TROPIC VIRUS POPULATIONS [J].
SCHUITEMAKER, H ;
KOOT, M ;
KOOTSTRA, NA ;
DERCKSEN, MW ;
DEGOEDE, REY ;
VANSTEENWIJK, RP ;
LANGE, JMA ;
SCHATTENKERK, JKME ;
MIEDEMA, F ;
TERSMETTE, M .
JOURNAL OF VIROLOGY, 1992, 66 (03) :1354-1360
[63]   Stability of the latent reservoir for HIV-1 in patients receiving valproic acid [J].
Siliciano, Janet D. ;
Lai, Jun ;
Callender, Marc ;
Pitt, Eleanor ;
Zhang, Hao ;
Margolick, Joseph B. ;
Gallant, Joel E. ;
Cofrancesco, Joseph, Jr. ;
Moore, Richard D. ;
Gange, Stephen J. ;
Siliciano, Robert F. .
JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (06) :833-836
[64]   Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction [J].
Trautmann, Lydie ;
Janbazian, Loury ;
Chomont, Nicolas ;
Said, Elias A. ;
Gimmig, Sylvain ;
Bessette, Benoit ;
Boulassel, Mohamed-Rachid ;
Delwart, Eric ;
Sepulveda, Homero ;
Balderas, Robert S. ;
Routy, Jean-Pierre ;
Haddad, Elias K. ;
Sekaly, Rafick-Pierre .
NATURE MEDICINE, 2006, 12 (10) :1198-1202
[65]   Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation [J].
VanLint, C ;
Emiliani, S ;
Ott, M ;
Verdin, E .
EMBO JOURNAL, 1996, 15 (05) :1112-1120
[66]   Enhancing SIV-specific immunity in vivo by PD-1 blockade [J].
Velu, Vijayakumar ;
Titanji, Kehmia ;
Zhu, Baogong ;
Husain, Sajid ;
Pladevega, Annette ;
Lai, Lilin ;
Vanderford, Thomas H. ;
Chennareddi, Lakshmi ;
Silvestri, Guido ;
Freeman, Gordon J. ;
Ahmed, Rafi ;
Amara, Rama Rao .
NATURE, 2009, 458 (7235) :206-U5
[67]   Safety and Efficacy of an Oral Histone Deacetylase Inhibitor in Systemic-Onset Juvenile Idiopathic Arthritis [J].
Vojinovic, Jelena ;
Damjanov, Nemanja ;
D'Urzo, Carmine ;
Furlan, Antonio ;
Susic, Gordana ;
Pasic, Srdjan ;
Iagaru, Nicola ;
Stefan, Mariana ;
Dinarello, Charles A. .
ARTHRITIS AND RHEUMATISM, 2011, 63 (05) :1452-1458
[68]   Emergence of CXCR4-Using human immunodeficiency virus type 1 (HIV-1) variants in a minority of HIV-1-Infected patients following treatment with the CCR5 antagonist maraviroc is from a pretreatment CXCR4-using virus reservoir [J].
Westby, M ;
Lewis, M ;
Whitcomb, J ;
Youle, M ;
Pozniak, AL ;
James, IT ;
Jenkins, TM ;
Perros, M ;
van der Ryst, E .
JOURNAL OF VIROLOGY, 2006, 80 (10) :4909-4920
[69]   T cell exhaustion [J].
Wherry, E. John .
NATURE IMMUNOLOGY, 2011, 12 (06) :492-499
[70]   HDAC inhibitors in HIV [J].
Wightman, Fiona ;
Ellenberg, Paula ;
Churchill, Melissa ;
Lewin, Sharon R. .
IMMUNOLOGY AND CELL BIOLOGY, 2012, 90 (01) :47-54